Glenview Capital Management LLC boosted its position in Monsanto Company (NYSE:MON) by 16.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 355,764 shares of the basic materials company’s stock after buying an additional 51,364 shares during the period. Glenview Capital Management LLC owned approximately 0.08% of Monsanto worth $40,272,000 as of its most recent filing with the SEC.
A number of other institutional investors have also recently added to or reduced their stakes in MON. Gotham Asset Management LLC increased its stake in Monsanto by 98.4% in the first quarter. Gotham Asset Management LLC now owns 164,239 shares of the basic materials company’s stock valued at $18,592,000 after buying an additional 81,463 shares during the last quarter. Soros Fund Management LLC bought a new stake in Monsanto during the first quarter valued at approximately $4,907,000. Highbridge Capital Management LLC bought a new stake in Monsanto during the first quarter valued at approximately $20,376,000. Paulson & CO. Inc. bought a new stake in Monsanto during the first quarter valued at approximately $4,019,000. Finally, Level Four Advisory Services LLC increased its stake in Monsanto by 10.5% in the first quarter. Level Four Advisory Services LLC now owns 9,382 shares of the basic materials company’s stock valued at $1,082,000 after buying an additional 889 shares during the last quarter. 75.31% of the stock is owned by hedge funds and other institutional investors.
Shares of Monsanto Company (NYSE MON) opened at 116.55 on Friday. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $118.97. The firm has a market capitalization of $51.20 billion, a price-to-earnings ratio of 25.17 and a beta of 1.07. The stock’s 50 day moving average price is $117.47 and its 200 day moving average price is $115.08.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. During the same period in the previous year, the company posted $2.17 EPS. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. Equities research analysts expect that Monsanto Company will post $4.89 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be paid a dividend of $0.54 per share. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.85%. Monsanto’s payout ratio is 46.75%.
COPYRIGHT VIOLATION NOTICE: “Glenview Capital Management LLC Raises Stake in Monsanto Company (NYSE:MON)” was reported by Transcript Daily and is owned by of Transcript Daily. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://transcriptdaily.com/2017/08/13/monsanto-company-nysemon-shares-bought-by-glenview-capital-management-llc-updated-updated.html.
Several equities research analysts have recently commented on MON shares. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective for the company in a report on Friday, June 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective for the company in a report on Thursday, July 6th. BidaskClub downgraded Monsanto from a “hold” rating to a “sell” rating in a report on Sunday, July 16th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $128.00 price objective (up previously from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Finally, UBS AG cut Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $123.15.
In related news, EVP Robert T. Fraley sold 52,410 shares of the business’s stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Steven Mizell sold 11,300 shares of the business’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the sale, the executive vice president now owns 55,011 shares in the company, valued at $6,522,654.27. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 74,470 shares of company stock worth $8,791,281. 0.79% of the stock is currently owned by corporate insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.